KNAW

Back to search results
Prof.dr. A.F.H. Stalenhoef Person

Prof.dr. A.F.H. Stalenhoef

Pagina-navigatie:


Update Persondata


Export page
Expertise Atherosclerosis, cardiometabolic risk factors, cardiovascular diseases, dyslipidemias, dyslipoproteinemias, inflammatory cytokines, cardiovascular risk polymorphisms, novel lipid-lowering and anti-inflammatory agents (glitazones, statins)
Expertise (NL) Atherosclerosis, cardiometabolic risk factors, cardiovascular diseases, dyslipidemias, dyslipoproteinemias, inflammatory cytokines, cardiovascular risk polymorphisms, novel lipid-lowering and anti-inflammatory agents (glitazones, statins)
Digital Author ID info:eu-repo/dai/nl/068700415
Addition Bestuurslid Ned. Vereniging voor Vasculaire Geneeskunde; Bestuurslid Dutch Atherosclerosis Society; Bestuurlid European Atherosclerosis Society; Hoofdredacteur Netherlands Journal of Medicine; Lid Gezondheidsraad

Active as

Professor
Organisation Department of General Internal Medicine (RU)
Chair (EN) Atherogenesis
Chair (NL) Atherogenese
Phone +31-24-3616552
Email A. Stalenhoef -at- AIG. umcn. nl
URL http://organisatiegids.ru.nl/tabOnderzoek.aspx?RBSID=101208

Publications

(the most recent at the top)
Van vaten, bloeddruk en vetten
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
Should preclinical vascular abnormalities be measured in asymptomatic adults to improve cardiovascular risk stratification?
Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1beta transcription in human adipose tissue
Oxidized LDL enhances pro-inflammatory responses of alternatively activated M2 macrophages: a crucial role for Kruppel-like factor 2
All publications..

Classification

D21300 Biochemistry
D23222 Cardiovascular disorders

Go to page top
Go back to contents
Go back to site navigation